The Efficacy for Hypertensive Intracerebral Hemorrhage Between Neuroendoscopic Surgery and Conservative Treatment A Retrospective Observational

Objectives: This study aims to investigate the efficacy of neuro-endoscopic surgery in the treatment of hypertensive intracerebral hemorrhage (HICH). Methods: A total of 193 patients diagnosed with HICH were divided into 2 groups in this study: the observation group (n= 101) received neuroendoscopic surgery, whereas the control group (n= 92) underwent conservative treatment. Then, the outcomes between these 2 groups were compared and assessed. Results: In the pretreatment phase, there were no significant differences in the levels of inflammation and neurological function scores between these 2 groups (P> 0.05). After 3 months of treatment, the observation group displayed significantly shorter median hospital stay, lower average hospital costs, and faster hematoma resorption time, along with reduced levels of tumor necrosis factoralpha (TNF-a), C-reactive protein (CRP), interleukin (IL)-6 and IL8, aquaporin-4 (AQP4), macrophage migration inhibitory factor (MIF), matrix metalloproteinase-9 (MMP-9), granulocyte macrophage colony stimulating factor (GM-CSF), Nerve Deficiency Scale (NDS), Graeb score, and national institute of health stroke scale (NIHSS) compared with the control group (P< 0.05). In addition, the observation group exhibited higher rate of hematoma clearance and better glasgow outcome scale (GOS) score compared with the control group (P< 0.05). The effective treatment rate in the observation group was notably superior to that in the control group (89.11% vs. 73.91%, P< 0.05). Conclusions: Neuroendoscopic surgery is an effective treatment for HICH, with alleviating the inflammatory response and enhancing the neurological function. The treatment shows promising outcomes and justifies extensive implementation.